BioNexus Gene Lab Corp Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BioNexus Gene Lab Corp quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • BioNexus Gene Lab Corp Return On Equity for the quarter ending September 30, 2024 was -9.93 %, a 77.7% increase year-over-year.
  • BioNexus Gene Lab Corp annual Return On Equity for 2023 was -34.2 %, a 549% decline from 2022.
  • BioNexus Gene Lab Corp annual Return On Equity for 2022 was -5.27 %, a 149% decline from 2021.
  • BioNexus Gene Lab Corp annual Return On Equity for 2021 was 10.8 %, a 36.5% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -34.2 -28.9 -549% Jan 1, 2023 Dec 31, 2023
2022 -5.27 -16.1 -149% Jan 1, 2022 Dec 31, 2022
2021 10.8 -6.2 -36.5% Jan 1, 2021 Dec 31, 2021
2020 17 +35.8 Jan 1, 2020 Dec 31, 2020
2019 -18.8 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.